Edith A. Perez
- a cancer specialist and an internationally known translational researcher who holds positions at both Genentech and Mayo Clinic.
- She is the Director of the Mayo Clinic Breast Cancer Translational Genomics Program started in 2009 and a Professor of Medicine at Mayo Medical School.
- In August 2015, Dr. Perez joined Genentech US Medical Affairs (USMA) as Vice President and Head of the BioOncology Medical Unit. In
- In 2005, she revealed the results of the North Central Cancer Treatment Group N9831 Intergroup trial, of which she was the principal investigator. The results showed a considerable decrease in recurrence and increase in the survival of patients with HER2-positive breast cancer after the inclusion of trastuzumab to adjuvant chemotherapy.
- Dr. Perez has authored more than 300 peer-reviewed articles. She has held positions within Mayo Clinic, the American Association for Cancer Research, the American Society of Clinical Oncology, and the National Cancer Institute.
- Dr. Perez earned her medical degree from the University of Puerto Rico School of Medicine in San Juan and completed her residency in internal medicine at the Loma Linda University Medical Center in California. She served as general internist in the Division of National Health Services Corps, Los Angeles, and as a fellow in Hematology/Oncology at Martinez Veterans’ Administration Medical Center at the University of California, Davis School of Medicine. Dr. Perez is board certified in internal medicine, internal medicine – medical oncology and internal medicine – hematology.